Global Ursodeoxycholic Acid Market Growth 2025-2031

Global Ursodeoxycholic Acid Market Growth 2025-2031

The global Ursodeoxycholic Acid market size is predicted to grow from US$ 544 million in 2025 to US$ 970 million in 2031; it is expected to grow at a CAGR of 10.1% from 2025 to 2031.

Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.

The growing prevalence of liver diseases, such as primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and certain forms of liver cirrhosis, serves as a significant driver for the Ursodeoxycholic Acid (UDCA) market. As more individuals are diagnosed with these conditions due to improved medical awareness and diagnostic techniques, the demand for effective treatments like UDCA increases. UDCA has demonstrated efficacy in managing and alleviating symptoms of these liver diseases, positioning it as a valuable therapeutic option. The rising global burden of liver disorders, often associated with factors like aging and lifestyle changes, provides a sustained demand for UDCA as a key component in manufacturing medications to address these conditions.

One of the major challenges faced by the UDCA API market is the high cost of production, which can limit accessibility, especially in developing regions. The complex extraction and synthesis process of UDCA contributes to its expensive manufacturing, making it difficult for pharmaceutical companies to offer cost-effective treatments. Additionally, regulatory hurdles and stringent quality standards for drug approval add further pressure on manufacturers, which may slow down market growth.

APAC is the largest consumption place, with a consumption market share nearly 52% in 2023. Following APAC, Europe is the second largest consumption place with the consumption market share of 30%.

Global key Ursodeoxycholic Acid players cover ICE, Dipharma Francis, Daewoong Chemical, Zhongshan Bailing, PharmaZell GmbH, Suzhou Tianlv, Yun Gang Bio, Grindeks, etc. In terms of revenue, the global five largest companies occupied for a share nearly 72% in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Ursodeoxycholic Acid Industry Forecast” looks at past sales and reviews total world Ursodeoxycholic Acid sales in 2024, providing a comprehensive analysis by region and market sector of projected Ursodeoxycholic Acid sales for 2025 through 2031. With Ursodeoxycholic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ursodeoxycholic Acid industry.

This Insight Report provides a comprehensive analysis of the global Ursodeoxycholic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ursodeoxycholic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ursodeoxycholic Acid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ursodeoxycholic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ursodeoxycholic Acid.

This report presents a comprehensive overview, market shares, and growth opportunities of Ursodeoxycholic Acid market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Synthetic UDCA
Extraction UDCA

Segmentation by Application:
Pharmacy
Health Products

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan Bailing
Dipharma Francis
Grindeks
Suzhou Tianlv
Yun Gang Bio

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ursodeoxycholic Acid market?

What factors are driving Ursodeoxycholic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ursodeoxycholic Acid market opportunities vary by end market size?

How does Ursodeoxycholic Acid break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.